Maptelligent, Inc. MAPT
0.00 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
0.0005 Day range 0.0005
0.0001 52-week range 0.001
- YTD
- +233.33%
- 1 year
- +233.33%
News
seekingalpha.com Arrowhead Pharmaceuticals: ARO-MAPT Results Unlock A New Platform Arrowhead Pharmaceuticals, Inc. exceeded expectations with ARO-MAPT phase 1 results, achieving up to 85% CSF tau reduction and validating its subcutaneous CNS siRNA platform. ARWR plans to expand its…
businesswire.com Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from an ongoing Phase 1/2a study of ARO-MAPT, the company's investigational RNA…
businesswire.com Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its plan to host an R&D webinar on Wednesday, October 14, 2026, at 11:30 AM PDT that will…
gurufocus.com Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer's Disease [url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that its partner, Biogen, shared data from the Phase 2 CELIA study evaluating diranerse
businesswire.com Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the…
businesswire.com Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer's Disease and Other Tauopathies PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical…
globenewswire.com Maptelligent, Inc., is Pleased to Announce it has Entered Into an Agreement With Axim Geospatial LAS VEGAS, NV, Dec. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maptelligent, Inc., (OTC PK: MAPT) www.maptelligent.com – Axim Geospatial is to provide Maptelligent complete GIS services with…
globenewswire.com Maptelligent is Pleased to Announce Its New Strategic Focus, Implementing the Latest in Location Intelligence Making Indoor Maps More Intelligent LAS VEGAS, NV, Feb. 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maptelligent, Inc., (OTC PK: MAPT) www.maptelligent.com, its where indoor maps become intelligent. Maptelligent, Inc., has a new…
globenewswire.com Maptelligent, Inc., is Pleased to Announce a Partnership with Michael Quan with the Interactive Tactical Group LAS VEGAS, NV, Nov. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Maptelligent, Inc. (OTC PK: MAPT), www.maptelligent.com.
globenewswire.com NSION Technologies & Maptelligent Strategic Partnership LAS VEGAS, NV, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc., (MAPT) has partnered with NSION Technologies to provide secure and enhanced situational awareness using real…
globenewswire.com Maptelligent, Inc., is Pleased to Announce Its New Management Services Agreement With Mr. Christopher Oudegeest, the Founder of Asbuilt Conditions LAS VEGAS, NV, Sept. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc., (OTC PK: MAPT) www.maptelligent.com :
globenewswire.com Maptelligent, Inc. is Pleased to Announce Its New Strategic Partnership With the Award-winning Kant Consulting Group LAS VEGAS, NV, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTC PK: MAPT) www.maptelligent.com:
globenewswire.com Maptelligent, Inc. Announces Mr. Joel Rothschild as Chief Technical Officer LAS VEGAS, NV, July 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTC PK: MAPT) is pleased to announce that Mr. Joel Rothschild has joined Maptelligent, Inc., as its Chief…
globenewswire.com Maptelligent, Inc., Rebranding Efforts With the Launch of a New Website LAS VEGAS, NV, June 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTC PK: MAPT) www.maptelligent.com :
globenewswire.com Maptelligent, Inc., Solution Innovation Las Vegas, Nevada, June 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc., (OTCPK:MAPT), (www.maptelligent.com) is a company which provides indoor mapping capabilities for facility…
globenewswire.com Maptelligent, Inc., Executes an Agreement With GeoComm, Inc. Las Vegas, NV, April 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTCPK: MAPT) is pleased to announce, our recent agreement with GeoComm, the leading provider of Public Safety…
globenewswire.com UPDATE -- Maptelligent, Inc. Announces Mr. Eric Kant of Kant Consulting Group, LLC as a Consultant LAS VEGAS, NV, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maptelligent, Inc. (OTC PK: MAPT), is pleased to announce, the official engagement as a consultant with Mr. Eric H. Kant the…